Serum levels of perfluorinated compounds and sperm Y: X chromosome ratio in two European populations and in Inuit from Greenland

Reproductive Toxicology

Volumn 34, Issue 4, 2012, Pages 644-650

  Kvist, Linus ^a   Giwercman, Yvonne Lundberg ^a   Jönsson, Bo A G ^a   Lindh, Christian H ^a   Bonde, Jens Peter ^b   Toft, Gunnar ^c   Strucinski, Pawel ^d   Pedersen, Henning S ^e   Zvyezday, Valentyna ^f   Giwercman, Aleksander ^g  

^a LUND UNIVERSITY   (Sweden)

^b Mental Health Center Glostrup   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d NATIONAL INSTITUTE OF HYGIENE   (Poland)

^e Center of Arctic Environmental Medicine   (Greenland)

^f KHARKIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Perfluorooctanesulfonate; Perfluorooctanoic acid; Y:X chromosome ratio

Indexed keywords

PERFLUORO COMPOUND; PERFLUOROOCTANESULFONIC ACID;

ARTICLE; ESKIMO; EUROPE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GREENLAND; HUMAN; LINEAR REGRESSION ANALYSIS; LIQUID CHROMATOGRAPHY; MALE; MULTIVARIATE ANALYSIS OF VARIANCE; POLAND; POPULATION EXPOSURE; REPRODUCTIVE TOXICITY; SEX RATIO; SPERM; TANDEM MASS SPECTROMETRY; UKRAINE; X CHROMOSOME; Y CHROMOSOME;

ALKANESULFONIC ACIDS; CAPRYLATES; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FLUOROCARBONS; GREENLAND; HUMANS; INUITS; MALE; SPERMATOZOA;

ANIMALIA;

EID: 84868224674     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2012.09.007     Document Type: Article

References (68)

1. Juntunen K.S., Kvist A.P., Kauppila A.J. A shift from a male to a female majority in newborns with the increasing age of grand grand multiparous women. Human Reproduction 1997, 12:2321-2323.
2. Biggar R.J., Wohlfahrt J., Westergaard T., Melbye M. Sex ratios, family size, and birth order. American Journal of Epidemiology 1999, 150:957-962.
3. Fukuda M., Fukuda K., Shimizu T., Moller H. Decline in sex ratio at birth after Kobe earthquake. Human Reproduction 1998, 13:2321-2322.
4. Zorn B., Sucur V., Stare J., Meden-Vrtovec H. Decline in sex ratio at birth after 10-day war in Slovenia: brief communication. Human Reproduction 2002, 17:3173-3177.
5. Mathews T.J., Hamilton B.E. Trend analysis of the sex ratio at birth in the United States. National Vital Statistics Reports 2005, 53:1-17.
6. Davis D.L., Gottlieb M.B., Stampnitzky J.R. Reduced ratio of male to female births in several industrial countries: a sentinel health indicator?. JAMA 1998, 279:1018-1023.
7. Rjasanowski I., Kloting I., Kovacs P. Altered sex ratio in offspring of mothers with insulin-dependent diabetes mellitus. Lancet 1998, 351:497-498.
8. Weinberg C.R., Baird D.D., Wilcox A.J. The sex of the baby may be related to the length of the follicular phase in the conception cycle. Human Reproduction 1995, 10:304-307.
9. Davis D.L., Webster P., Stainthorpe H., Chilton J., Jones L., Doi R. Declines in sex ratio at birth and fetal deaths in Japan, and in US whites but not African Americans. Environmental Health Perspectives 2007, 115:941-946.
10. Grech V., Vassallo-Agius P., Savona-Ventura C. Secular trends in sex ratios at birth in North America and Europe over the second half of the 20th century. Journal of Epidemiology and Community Health 2003, 57:612-615.
11. James W.H. Hormonal control of sex ratio. Journal of Theoretical Biology 1986, 118:427-441.
12. Rittler M., Castilla E.E. Endocrine disruptors and congenital anomalies. Cadernos de Saude Publica 2002, 18:421-428.
13. Mocarelli P., Gerthoux P.M., Ferrari E., Patterson D.G., Kieszak S.M., Brambilla P., et al. Paternal concentrations of dioxin and sex ratio of offspring. Lancet 2000, 355:1858-1863.
14. Smits L.J., de Bie R.A., Essed G.G., van den Brandt P.A. Time to pregnancy and sex of offspring: cohort study. BMJ 2005, 331:1437-1438.
15. Olsen J. Time to pregnancy and sex ratio of offspring. Electronic response to Smits LJ et al, Time to pregnancy and sex of offspring: cohort study. BMJ 2005, 331:1437-1438.
16. Bonde J.P., Wilcox A. Ratio of boys to girls at birth. BMJ 2007, 334:486-487.
17. Buck R.C., Franklin J., Berger U., Conder J.M., Cousins I.T., de Voogt P., et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integrated Environmental Assessment and Management 2011, 7:513-541.
18. Martin J.W., Asher B.J., Beesoon S., Benskin J.P., Ross M.S. PFOS or PreFOS? Are perfluorooctane sulfonate precursors (PreFOS) important determinants of human and environmental perfluorooctane sulfonate (PFOS) exposure?. Journal of Environmental Monitoring 2010, 12:1979-2004.
19. Lindstrom A.B., Strynar M.J., Libelo E.L. Polyfluorinated compounds: past, present, and future. Environmental Science and Technology 2011, 45:7954-7961.
20. Vestergren R., Cousins I.T. Tracking the pathways of human exposure to perfluorocarboxylates. Environmental Science and Technology 2009, 43:5565-5575.
21. Giesy J.P., Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environmental Science and Technology 2001, 35:1339-1342.
22. Prevedouros K., Cousins I.T., Buck R.C., Korzeniowski S.H. Sources, fate and transport of perfluorocarboxylates. Environmental Science and Technology 2006, 40:32-44.
23. Kato K., Wong L.Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the US population: 1999-2008. Environmental Science and Technology 2011, 45:8037-8045.
24. Olsen G.W., Lange C.C., Ellefson M.E., Mair D.C., Church T.R., Goldberg C.L., et al. Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010. Environmental Science and Technology 2012, 46:6330-6338.
25. Wang M., Park J.S., Petreas M. Temporal changes in the levels of perfluorinated compounds in California women's serum over the past 50 years. Environmental Science and Technology 2011, 45:7510-7516.
26. Fromme H., Tittlemier S.A., Volkel W., Wilhelm M., Twardella D. Perfluorinated compounds - exposure assessment for the general population in Western countries. International Journal of Hygiene and Environmental Health 2009, 212:239-270.
27. Zhang T., Wu Q., Sun H.W., Zhang X.Z., Yun S.H., Kannan K. Perfluorinated compounds in whole blood samples from infants, children, and adults in China. Environmental Science and Technology 2010, 44:4341-4347.
28. Haug L.S., Thomsen C., Becher G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environmental Science and Technology 2009, 43:2131-2136.
29. Vassiliadou I., Costopoulou D., Ferderigou A., Leondiadis L. Levels of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) in blood samples from different groups of adults living in Greece. Chemosphere 2010, 80:1199-1206.
30. Ingelido A.M., Marra V., Abballe A., Valentini S., Iacovella N., Barbieri P., et al. Perfluorooctanesulfonate and perfluorooctanoic acid exposures of the Italian general population. Chemosphere 2010, 80:1125-1130.
31. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug and Chemical Toxicology 2000, 23:603-620.
32. Olsen G.W., Zobel L.R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. International Archives of Occupational and Environmental Health 2007, 81:231-246.
33. Falandysz J., Taniyasu S., Gulkowska A., Yamashita N., Schulte-Oehlmann U. Is fish a major source of fluorinated surfactants and repellents in humans living on the Baltic Coast?. Environmental Science and Technology 2006, 40:748-751.
34. Haug L.S., Thomsen C., Brantsaeter A.L., Kvalem H.E., Haugen M., Becher G., et al. Diet and particularly seafood are major sources of perfluorinated compounds in humans. Environment International 2010, 36:772-778.
35. Rylander C., Sandanger T.M., Froyland L., Lund E. Dietary patterns and plasma concentrations of perfluorinated compounds in 315 Norwegian women: the NOWAC Postgenome Study. Environmental Science and Technology 2010, 44:5225-5232.
36. (EFSA) EFSA Perfluoroalkylated substances in food: occurrence and dietary exposure. EFSA Journal 2012, 10.
37. D'Eon J.C., Mabury S.A. Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans?. Environmental Science and Technology 2011, 45:7974-7984.
38. Jensen A.A., Leffers H. Emerging endocrine disrupters: perfluoroalkylated substances. International Journal of Andrology 2008, 31:161-169.
39. Joensen U.N., Bossi R., Leffers H., Jensen A.A., Skakkebaek N.E., Jorgensen N. Do perfluoroalkyl compounds impair human semen quality?. Environmental Health Perspectives 2009, 117:923-927.
40. Specht I.O., Hougaard K.S., Spano M., Bizzaro D., Manicardi G.C., Lindh C.H., et al. Sperm DNA integrity in relation to exposure to environmental perfluoroalkyl substances - a study of spouses of pregnant women in three geographical regions. Reproductive Toxicology 2012, 33:577-583.
41. Raymer J.H., Michael L.C., Studabaker W.B., Olsen G.W., Sloan C.S., Wilcosky T., et al. Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements. Reproductive Toxicology 2012, 33:419-427.
42. York R.G., Kennedy G.L., Olsen G.W., Butenhoff J.L. Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance. Toxicology 2010, 271:64-72.
43. Olsen G.W., Butenhoff J.L., Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reproductive Toxicology 2009, 27:212-230.
44. Savitz D.A., Stein C.R., Bartell S.M., Elston B., Gong J., Shin H.M., et al. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 2012, 23:386-392.
45. Savitz D.A., Stein C.R., Elston B., Wellenius G.A., Bartell S.M., Shin H.M., et al. Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-ohio valley. Environmental Health Perspectives 2012, 120:1201-1207.
46. Stein C.R., Savitz D.A., Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. American Journal of Epidemiology 2009, 170:837-846.
47. Stein C.R., Savitz D.A. Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age. Environmental Health Perspectives 2011, 119:1466-1471.
48. Toft G., Axmon A., Giwercman A., Thulstrup A.M., Rignell-Hydbom A., Pedersen H.S., et al. Fertility in four regions spanning large contrasts in serum levels of widespread persistent organochlorines: a cross-sectional study. Environ Health 2005, 4:26.
49. Lindh C.H., Rylander L., Toft G., Axmon A., Rignell-Hydbom A., Giwercman A., et al. Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations. Chemosphere 2012, 88:1269-1275.
50. Tiido T., Rignell-Hydbom A., Jonsson B., Giwercman Y.L., Rylander L., Hagmar L., et al. Exposure to persistent organochlorine pollutants associates with human sperm Y:X chromosome ratio. Human Reproduction 2005, 20:1903-1909.
51. Tiido T., Rignell-Hydbom A., Jonsson B.A., Giwercman Y.L., Pedersen H.S., Wojtyniak B., et al. Impact of PCB and p,p'-DDE contaminants on human sperm Y:X chromosome ratio: studies in three European populations and the Inuit population in Greenland. Environmental Health Perspectives 2006, 114:718-724.
52. Duchon J. Splines minimizing rotation invariant seminorms in Sobolev spaces. Constructive theory of functions of several variables: proceedings of a conference 1977, 85-100. Springer-Verlag, Berlin. 571 ed. W. Schempp, K. Zeller (Eds.).
53. Seacat A.M., Thomford P.J., Hansen K.J., Olsen G.W., Case M.T., Butenhoff J.L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicological Sciences 2002, 68:249-264.
54. Wei Y., Liu Y., Wang J., Tao Y., Dai J. Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus). Toxicology and Applied Pharmacology 2008, 226:285-297.
55. Biegel L.B., Liu R.C., Hurtt M.E., Cook J.C. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicology and Applied Pharmacology 1995, 134:18-25.
56. Olsen G.W. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. Journal of Occupational Environmental Medicine 1998, 40:614-622.
57. Shi Z., Zhang H., Liu Y., Xu M., Dai J. Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicological Sciences 2007, 98:206-215.
58. Andersson A.M., Jorgensen N., Frydelund-Larsen L., Rajpert-De Meyts E., Skakkebaek N.E. Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls. Journal of Clinical Endocrinology and Metabolism 2004, 89:3161-3167.
59. Holm M., Rajpert-De Meyts E., Andersson A.M., Skakkebaek N.E. Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio. Journal of Pathology 2003, 199:378-386.
60. La Rocca C., Alessi E., Bergamasco B., Caserta D., Ciardo F., Fanello E., et al. Exposure and effective dose biomarkers for perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in infertile subjects: preliminary results of the PREVIENI project. International Journal of Hygiene and Environmental Health 2011, 215:206-211.
61. Chang S.C., Thibodeaux J.R., Eastvold M.L., Ehresman D.J., Bjork J.A., Froehlich J.W., et al. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 2008, 243:330-339.
62. Chang S.C., Thibodeaux J.R., Eastvold M.L., Ehresman D.J., Bjork J.A., Froehlich J.W., et al. Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 2007, 234:21-33.
63. Luebker D.J., York R.G., Hansen K.J., Moore J.A., Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 2005, 215:149-169.
64. Butenhoff J.L., Kennedy G.L., Frame S.R., O'Connor J.C., York R.G. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 2004, 196:95-116.
65. de Maat M.P., Bladbjerg E.M., Johansen L.G., de Knijff P., Gram J., Kluft C., et al. DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit - is there a relation with the low risk of cardiovascular disease in the Inuit?. Thrombosis and Haemostasis 1999, 81:547-552.
66. Giwercman Y.L., Kleist K.E., Giwercman A., Giwercman C., Toft G., Bonde J.P., et al. Remarkably low incidence of hypospadias in Greenland despite high exposure to endocrine disrupters; possible protective effect of androgen receptor genotype. Pharmacogenet Genomics 2006, 16:375-377.
67. Johannisson R., Leuschner E., Huppe M., Hinrichs F., Al-Hasani S., Diedrich K., et al. Increased frequency of X-bearing sperm in males from an infertility clinic: analysis by two-color fluorescence in situ hybridization. Cytogenetic and Genome Research 2002, 98:240-244.
68. Martin R.H., Spriggs E., Rademaker A.W. Multicolor fluorescence in situ hybridization analysis of aneuploidy and diploidy frequencies in 225,846 sperm from 10 normal men. Biology of Reproduction 1996, 54:394-398.